Trade Quince Therapeuticks Inc - QNCX CFD
Add to favourite- Summary
- Historical Data
| Spread | 0.0225 | ||||||||
|
Long position overnight fee
Long position overnight funding adjustment
Go to platform | -0.02629% | ||||||||
|
Short position overnight fee
Short position overnight funding adjustment
Go to platform | 0.004068% | ||||||||
| Overnight fee time | 21:00 (UTC) | ||||||||
| Min traded quantity | 1 | ||||||||
| Currency | USD | ||||||||
| Margin | 5.00% | ||||||||
| Stock exchange | United States of America | ||||||||
| Commission on trade | 0% |
| Prev. Close | 0.7677 |
| Open | 0.7746 |
| 1-Year Change | -33.73% |
| Day's Range | 0.7621 - 0.7792 |
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
| Date | Close | Change | Change (%) | Open | High | Low |
|---|---|---|---|---|---|---|
| Jul 25, 2024 | 0.7777 | 0.0403 | 5.47% | 0.7374 | 0.7977 | 0.7303 |
| Jul 24, 2024 | 0.7545 | 0.0187 | 2.54% | 0.7358 | 0.7576 | 0.7244 |
| Jul 23, 2024 | 0.7468 | 0.0291 | 4.05% | 0.7177 | 0.7550 | 0.7177 |
| Jul 22, 2024 | 0.7292 | 0.0044 | 0.61% | 0.7248 | 0.7447 | 0.7160 |
| Jul 19, 2024 | 0.7349 | -0.0028 | -0.38% | 0.7377 | 0.7661 | 0.7348 |
| Jul 18, 2024 | 0.7392 | -0.0255 | -3.33% | 0.7647 | 0.7647 | 0.7359 |
| Jul 17, 2024 | 0.7413 | 0.0036 | 0.49% | 0.7377 | 0.7688 | 0.7259 |
| Jul 16, 2024 | 0.7357 | -0.0020 | -0.27% | 0.7377 | 0.7523 | 0.7317 |
| Jul 15, 2024 | 0.7285 | -0.0292 | -3.85% | 0.7577 | 0.7577 | 0.7285 |
| Jul 12, 2024 | 0.7608 | -0.0597 | -7.28% | 0.8205 | 0.8205 | 0.7359 |
| Jul 11, 2024 | 0.7677 | 0.0528 | 7.39% | 0.7149 | 0.7677 | 0.6978 |
| Jul 10, 2024 | 0.7085 | 0.0036 | 0.51% | 0.7049 | 0.7250 | 0.6979 |
| Jul 9, 2024 | 0.7077 | 0.0100 | 1.43% | 0.6977 | 0.7277 | 0.6977 |
| Jul 8, 2024 | 0.7091 | -0.0107 | -1.49% | 0.7198 | 0.7198 | 0.6977 |
| Jul 5, 2024 | 0.7102 | 0.0103 | 1.47% | 0.6999 | 0.7248 | 0.6999 |
| Jul 3, 2024 | 0.6985 | -0.0213 | -2.96% | 0.7198 | 0.7248 | 0.6964 |
| Jul 2, 2024 | 0.7267 | 0.0090 | 1.25% | 0.7177 | 0.7449 | 0.7127 |
| Jul 1, 2024 | 0.7227 | 0.0253 | 3.63% | 0.6974 | 0.7305 | 0.6974 |
| Jun 28, 2024 | 0.7129 | 0.0180 | 2.59% | 0.6949 | 0.7351 | 0.6949 |
| Jun 27, 2024 | 0.7129 | -0.0119 | -1.64% | 0.7248 | 0.7305 | 0.6949 |
Trading calculator
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
- 1:1
- 20
- 100
- 500
- 1000
- 10000
Cortexyme Inc. Company profile
About Cortexyme Inc
Cortexyme, Inc. is a clinical stage biopharmaceutical company that is focused on providing disease-modifying therapeutics to treat Alzheimer's and other degenerative diseases. The Company provides 3CLpro inhibitor, COR803 product, is a lead compound for treatment of coronavirus infections. The Company’s products pipeline includes drug candidates for the treatment of central nervous system (CNS) disorders including Alzheimer’s disease; for the treatment of oncology applications including the prevention of oral squamous cell carcinoma, and for the treatment of underserved and chronic conditions such as periodontitis. The Company’s COR388 is for the treatment of Alzheimer’s disease and Parkinson's disease. The Company's COR588 is in Phase I clinical trial and targeting to use in the treatment of periodontal disease and other P. gingivalis-related indications. The Company is also developing COR588, is a second-generation brain penetrant lysine gingipain inhibitor.
Financial summary
BRIEF: For the fiscal year ended 31 December 2021, Cortexyme Inc revenues was not reported. Net loss increased 17% to $89.9M. Higher net loss reflects Stock-based Compensation in R&D increase from $7M to $15.1M (expense), Stock-based Compensation in GA increase of 99% to $14.8M (expense), General and administrative - Balancing increase of 45% to $14.7M (expense).
| Industry: | Biotechnology & Medical Research (NEC) |
601 Gateway Boulevard, Suite 1250
SOUTH SAN FRANCISCO
CALIFORNIA 94080
US
News
How to manage risk when trading
Learn what risk management is and find out how understanding about it could help you identify potential risks in your investment portfolio. Find out more.
06:57, 22 July 2024
ECB preview: lack of new data sees markets expecting a hold
Markets expect the ECB to keep rates unchanged in July but expectations for a September cut rise
13:13, 18 July 2024
What is an IPO and how does it work?
Learn about what an IPO is, why they are important, and how they work.
07:19, 10 July 2024
What are the biggest stock exchanges worldwide?
Discover the largest stock exchanges in the world by market capitalisation, including the Nasdaq Stock Market, the New York Stock Exchange and the London Stock Exchange.
12:44, 9 July 2024
Top ETFs
ETFs, or exchange-traded funds, offer traders a versatile gateway into the financial markets.
16:23, 8 July 2024
Lloyds forecast: will Lloyds share price return to £1? Third party data forecast
What’s next for Lloyds amid higher inflation and the start of a potential recessionary cycle in the UK?
14:00, 8 July 2024
RBNZ Preview: OCR expected to remain unchanged as central bank focuses on inflation
The Reserve Bank of New Zealand meets on Wednesday, July 10, 2024. We preview what to expect from the meeting and its possible impact on the NZD/USD.
13:25, 8 July 2024People also watch
Still looking for a broker you can trust?
Join the 630,000+ traders worldwide that chose to trade with Capital.com